PharmiWeb.com - Global Pharma News & Resources

Conference - Events

30-Nov-2022 - 02-Dec-2022
2022 hosts the race between IVERIC Bio and Apellis for regulatory approval of the very first marketable dry AMD treatment. In addition to clinical advances, the field will see plenty of technology advances for more patient-compliant therapeutics, with the favourable one-dose gene therapy approach addition to pipelines, and optimized biomarker technology. Join our 30+ expert speakers as we tackle the most critical roadblocks preventing your drugs getting the patients who need them. With companies such as Janssen, Apellis, Novartis, IVERIC, Genentech, AbbVie and more, we'll delve into the role of genetics, subretinal drusenoid deposits, lipid peroxidation and soft drusen in the progression dry AMD; realize the future of next generation biomarkers such as OCT technologies for novel structural…
3rd Dry AMD Therapeutics Summit
01-Dec-2022 - 01-Dec-2022
You'll already know if you're a winner. Your patients or customer are telling you. Now it's time for the rest of us to hear about it. We want to support you and applaud you. To motivate you to reach even further. Since the start of the pandemic, the pace of change in pharma has been nothing short of historic and it's at the Reuters Events Pharma USA Awards that you and your teams can pause, reflect - and celebrate, the great strides you have made to continue to improve patient outcomes and create value for customers - during truly unprecedented times. Reuters Events Pharma USA Awards is where pharma's leaders, pioneers, innovators come together to elevate and showcase those who are creating real value for customers and patients. There are many pharma awards ceremonies that reward the best…
Pharma Awards USA 2022
Clinion is delighted to announce that we will be exhibiting at “The Society for Clinical Data Management (SCDM)” a two-day event on “Capabilities, Collaboration, and Changes On The Way To Clinical Data Science” in Bangalore, India on December 2nd and 3rd, 2022. To advance clinical research, the SCDM annual conference brings together industry experts around the world to share CDM knowledge and education. SCDM promotes excellence in Clinical Data Management by offering innovative and thought-provoking content and networking opportunities. SCDM India offers attendees a unique opportunity to learn about cutting-edge solutions and best practices in Clinical Data Management. Clinion is excited to present the new and improved version of its eClinical Platform, which offers advanced features,…
Meet Clinion at SCDM India 2022 in Bangalore
This December, the 4th Annual Gene Therapy for Neurological Disorders meeting is returning to Boston to welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS. Join the expanding audience of gene therapy experts seeking to overcome the translational hurdles of developing gene therapies for CNS targets, from discovery, preclinical, translational, clinical, and commercial departments at the likes of Capsigen, AviadoBio, AskBio,Novartis, Prevail Therapeutics,Passage Bio,Voyager Therapeutics,UniQure and more. Group discounts and early booking rates are available. Please visit the website for full pricing information.
4th Annual Gene Therapy for Neurological Disorders
ENT organizing committee invites all the participants from all over the world to attend “8th European Otolaryngology-ENT Surgery Conference” during December 05-06, 2022 in Rome, Italy. which includes keynote presentations, Oral talks, Poster presentations and Exhibitions.
05-Dec-2022 - 06-Dec-2022
2nd Pharma Middle East Congress 2022 layout many new ideas to solve the most important problems relating to the health and wellbeing of humanity. With all the Experts and scientific people around the world focused on Novel trends and advanced strategies and Technologies emerging in Pharma and Chemistry research areas, it provides a unique learning and career-building opportunities in your profession to encourage the nascent research that you just can’t find anywhere else. PPMC 2022 presents a platform for the sharing & interaction of latest advancements between experts in the fields of pharmaceutics, drug delivery, biotechnology, nanotechnology from all over the globe. The esteemed event typically incorporates Keynote talks, Plenary sessions, Wor…
2nd Pharma Middle East Congress
The 8th Winter Process Conference will showcase presentations from International Chemists covering all aspects of Process Development. The speakers will discuss the latest issues in synthetic route design, development and optimisation, reactor design, work up and purification, crystallisation, process engineering, hazard studies and quality and regulatory issues. The presentations will be either from speakers within the chemical industry or academics with a strong link to industrial process development so the material presented with be of particular relevance to all chemists and engineers in industry as well as graduate students considering a career in industry. YOUNG CHEMIST AWARD Scientific Update would like to invite 2nd , 3rd or 4th year PhD students to present their work at the above…
8th Winter Process Chemistry Conference
Success of prostate cancer treatments has triggered a seismic shift in the status of the TRP field over the last year and sparked more research investment than ever before. The Targeted Radiopharmaceuticals Summit Europe returns for its fourth year as the only event to address the needs of drug developers at all development stages, from both medical and operational perspectives. Overcome the technical, logistical, and translational hurdles of radionuclide therapy development. This event will bring together clinical, logistical and manufacturing experts from radiopharma and academia to help you accelerate your development programmes, tackle supply chain issues and harness alpha- and beta- emitting radionuclides to take on new cancers.
4th Targeted Radiopharmaceuticals Europe
06-Dec-2022 - 08-Dec-2022
With no room for error in the highly competitive ADC market and no going back after you have selected your target, it is vital that drug developers optimally triangulate the linker-payload, target and indication to develop an ADC that can have the biggest impact on patients. Recent exciting developments in linker-payload technologies and clinical efficacy in low-expressed tumors have propelled this conversation to the forefront of mind. We are at the cusp of seeing clinical improvements on previously validated targets, witnessing success on targets where previous ADCs have failed and engaging novel targets, widening the application of ADCs beyond what was thought. The 2nd ADC Target Selection Summit will provide you an A-Z coverage of the key considerations that ADC developers are making w…
2nd ADC Target Selection Summit
Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and PotencyFollowing the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.  The highly anticipated Lipid Nanoparticle Immunogenicity and Toxicity Summit takes place this December to unite 80+ senior leaders as the definitive meeting for clinical pharmacology, immunogenicity, bioanalytical development leaders to stay at the forefront, arming you with practical takeaways and lessons learned. Across 3 days, we will delve into: HW220702 LNP Immunogenicity and Toxicity logo…
Lipid Nanoparticles Immunogenicity and Toxicity
07-Dec-2022 - 08-Dec-2022
As immuno-oncology drug development transforms cancer treatment paradigms, preclinical and clinical data continues to demonstrate that the TIGIT axis blockade, particularly in combination with other immune checkpoint inhibitor partners, has strong efficacy. Despite recent clinical setbacks, and with at least 15 anti-TIGIT axis drugs in active clinical development, TIGIT axis targeting remains a promising treatment approach. In the context of a need to accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, b…
3rd TIGIT Axis Therapies
3rd Asian Public Mental Health Congress pertains to psychiatry and mental health disorders such as anxiety, depression, bipolar, behavioral disorders, post-traumatic, seasonal depression, persistent depressive disorder, stress management and understanding the effective diagnosis & treatment to facilitate the recovery from psychiatric disorders. Conference Central Topics: Neurology and Mental Health Human Resilience Epilepsy and Brain Disorder Addiction and Mental Health Stress, Anxiety and Depression Child and Adolescent Mental Health Womens Mental Health Mental Disorders and Mental Illness Psychosocial Rehabilitation and Treatment Global Epidemiology of Mental Illness
3rd Asian Public Mental Health Congress
Expand and Maximize RNA Druggability with Small Molecules As one of the most anticipated events on the RNA calendar, the RNA-Targeted Drug Discovery Summit returns for its fifth year this December. This premier, definitive, and most comprehensive forum for the RNA-targeting small molecule community will address remaining challenges, including but not limited to RNA structure and function relationship, functional validation, and the translational route from discovery to pre-clinical and clinical development. This forum will deliver exclusive data from the movers and shakers in the RNA drug discovery field from the likes of Arrakis Therapeutics, Remix Therapeutics, ReviR Therapeutics Novartis, Roche, Eloxx Pharmaceuticals, Ribometrix, as well as true academic pioneers with the likes of Hashi…
5th Annual RNA-Targeted Drug Discovery Summit
11th Edition Medical Device Safety Monitoring Reporting And Surveillance Conforming to Regulatory Guidance for Improvements in Developing Robust Reporting and Surveillance Control Strategies Through Use of RWE January 17-19, 2023 | San Diego, CA We are excited to inform you about our upcoming Medical Device Safety Monitoring Reporting And Surveillance Conference which takes place on January 17 – 19, 2023 | San Diego, California. Attending this premier event, will show you how to recognize and interpret future regulatory improvements and increase cooperation between member states in data collection, reporting, vigilance, and market surveillance.   Attending this Premier Event Will Enable You To: Define relationship between post market surveillance and how it intersects with risk…
SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023. The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization. Engage in the latest innovations in device design, development and formulation, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease. The two-day agenda offers you peer-to-peer networking wit…
2nd Annual Transdermal and Microneedle Drug Delivery Conference
24-Jan-2023 - 26-Jan-2023
DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-treat CNS tumors. The 6th Annual DDR Inhibitors Summit will cover both the preclinical and clinical DDR inhibitor landscape and establish how the field is addressing the biggest hurdle to drug development – toxicity. From reviewing progress with both novel and established targets to utilizing inhibitors in combination studies and improving patient selection with improved biomarkers; this meeting will give a comprehensive and up-to-date overview of the field. As we look to 2023 and what it has in store, this highly anticipated su…
6th DDR Inhibitors Summit
We are glad to welcome you at our new destination in Zurich Switzerland on February 02-03, 2023 for our upcoming Event on 3rd World Congress on Surgery, Surgeons & Anesthesia organized by Surgeons Congress 2023. For More Details: https://surgeon.euroscicon.com/ The WCSS 2023 has turned in to a premier forum to network, learn and connect with experts, academicians, researchers, specialists and activists in generating a platform to discuss and spread meaningful messages, values and practices in the subject of Surgery. Highlights Surgery General Surgery Pediatric Surgery Surgical Oncology Surgical Pathology Acute Care Surgery Advancements In Surgery Vascular Surgery Anesthesiology And Perioperative Care Podiatric Surgery Bariatric Surgery Breast Surgery Cardiac Surgery Colorectal Surgery…
3rd World Congress on Surgery, Surgeons & Anesthesia
The Marketplaces for Pharma Business Opportunities are attended by top business development executives of drug developing, producing or marketing companies from all over the world. Each Marketplace is an online exchange for pharma business opportunities and a platform to arrange either real (in-person) or virtual (video) business meetings, or both. A two-days one-on-one meetings event in Singapore, is embedded in two video meeting weeks before and two weeks after the on-site event. The new format allows registrants to hold pre-event video meetings with other company representatives in order to clarify whether or not a personal, on-site meeting makes sense. It also allows to efficiently prepare for a personal on-site meeting and to clear up pertinent questions beforehand. The post-event vid…
asiaPLX 1 Singapore Marketplace for Pharma Business Opportunities
The marcus evans 16th Edition Pharmaceutical Resource Planning and Portfolio Management conference taking place in Philadelphia, PA on February 8-9, 2023 will present the most recent and useful analysis of management tools, digital technologies, and innovative strategies to grow your company amidst an increasingly difficult regulatory environment and a shift towards targeted medicine that will disrupt the future of pharma. Join your peers from Pharma and Biotech companies to master stakeholder and asset management, strategy, and technology to sustain a competitive advantage. Attending This Premier marcus evans Conference Will Enable You to: Develop a New Generation of PM Thought Leaders for Higher Employee Engagement and truly Transformational Organizational Value in the long term. Alloca…
16th Edition Pharmaceutical Resource Planning And Portfolio Management
08-Feb-2023 - 09-Feb-2023
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field. In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person eve…
14th Annual RNA Therapeutics